BUPIVACAINE

BUPIVACAINE was reported 9405 times

BUPIVACAINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARACHNOID WEB 6 0.4286
1 OCULOCARDIAC REFLEX 5 0.3125
2 MANIPULATION 6 0.2857
3 ANTERIOR SPINAL ARTERY SYNDROME 24 0.2857
4 MATERNAL EXPOSURE DURING DELIVERY 258 0.2603
5 INFUSION SITE FIBROSIS 5 0.2500
6 PLATELET AGGREGATION INHIBITION 15 0.1630
7 PURTSCHER RETINOPATHY 13 0.1585
8 CATHETER SITE GRANULOMA 9 0.1579
9 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 164 0.1544
10 INSPIRATORY CAPACITY DECREASED 41 0.1480
11 ACUTE MACULAR NEURORETINOPATHY 25 0.1462
12 OBSTETRIC PROCEDURE COMPLICATION 5 0.1351
13 BEZOLD-JARISCH REFLEX 5 0.1316
14 MATERNAL USE OF ILLICIT DRUGS 5 0.1316
15 FEMORAL NERVE PALSY 8 0.1250
16 HORNER'S SYNDROME 10 0.1205
17 CONUS MEDULLARIS SYNDROME 7 0.1077
18 FOETAL EXPOSURE DURING DELIVERY 73 0.1077
19 SPINAL ANAESTHESIA 8 0.1039
20 ARTHROFIBROSIS 10 0.0980
21 CHONDROLYSIS 46 0.0979
22 FEMORAL NERVE INJURY 7 0.0972
23 PAROPHTHALMIA 23 0.0966
24 HARLEQUIN SYNDROME 7 0.0959
25 VASCULAR RESISTANCE SYSTEMIC DECREASED 12 0.0896
26 ANAESTHETIC COMPLICATION CARDIAC 6 0.0870
27 IMPLANT SITE EXTRAVASATION 64 0.0814
28 MEDICAL DEVICE SITE PAIN 44 0.0782
29 PHRENIC NERVE PARALYSIS 17 0.0776
30 LAGOPHTHALMOS 30 0.0733
31 POST PROCEDURAL HYPOTENSION 6 0.0706
32 SPINAL CORD INFARCTION 31 0.0703
33 PULMONARY AIR LEAKAGE 10 0.0662
34 OVERLAP SYNDROME 46 0.0657
35 MEDICAL DEVICE SITE DISCHARGE 10 0.0654
36 THERAPEUTIC RESPONSE PROLONGED 6 0.0638
37 MEDICAL DEVICE SITE ERYTHEMA 8 0.0625
38 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 9 0.0559
39 ANAESTHETIC COMPLICATION 149 0.0554
40 URINARY RETENTION POSTOPERATIVE 9 0.0545
41 CAUDA EQUINA SYNDROME 39 0.0508
42 SYSTEMIC TOXICITY 10 0.0488
43 OPEN GLOBE INJURY 8 0.0485
44 MEDICAL DEVICE SITE SWELLING 8 0.0462
45 RHYTHM IDIOVENTRICULAR 15 0.0462
46 UTERINE ATONY 12 0.0458
47 BRACHIAL PLEXOPATHY 10 0.0452
48 NEUROMUSCULAR BLOCK PROLONGED 16 0.0434
49 THERAPEUTIC PRODUCT EFFECT PROLONGED 18 0.0397
50 NEONATAL RESPIRATORY ACIDOSIS 6 0.0395
51 PROCEDURAL HYPOTENSION 33 0.0388
52 BRADYCARDIA FOETAL 32 0.0385
53 AIRWAY COMPLICATION OF ANAESTHESIA 10 0.0380
54 BRACHIAL PLEXUS INJURY 6 0.0373
55 MENINGITIS CHEMICAL 8 0.0364
56 MYOPATHY TOXIC 22 0.0356
57 CARDIAC OUTPUT INCREASED 6 0.0351
58 ARACHNOIDITIS 24 0.0347
59 DELAYED RECOVERY FROM ANAESTHESIA 31 0.0327
60 DEVICE DAMAGE 26 0.0326
61 SPINAL CORD OEDEMA 12 0.0324
62 PROCEDURAL NAUSEA 26 0.0323
63 CHEST TUBE INSERTION 6 0.0319
64 POSTOPERATIVE ILEUS 18 0.0319
65 NEUROMUSCULAR BLOCKADE 7 0.0312
66 IMPLANT SITE MASS 6 0.0305
67 IMPLANT SITE HAEMATOMA 7 0.0287
68 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 250 0.0282
69 EXTRADURAL HAEMATOMA 37 0.0280
70 PROCEDURAL VOMITING 18 0.0277
71 MEAN ARTERIAL PRESSURE DECREASED 7 0.0277
72 PARALYSIS FLACCID 6 0.0274
73 FOETAL HEART RATE DECELERATION ABNORMALITY 19 0.0269
74 ANAESTHETIC COMPLICATION NEUROLOGICAL 24 0.0265
75 INTRAOCULAR PRESSURE FLUCTUATION 5 0.0254
76 POST LUMBAR PUNCTURE SYNDROME 26 0.0250
77 HYPONATRAEMIC ENCEPHALOPATHY 5 0.0248
78 DEVICE BATTERY ISSUE 16 0.0243
79 CONJUNCTIVAL OEDEMA 23 0.0224
80 DEVICE INFUSION ISSUE 54 0.0218
81 DIAPHRAGMATIC PARALYSIS 13 0.0217
82 IMPLANT SITE DISCHARGE 8 0.0213
83 INFUSION SITE MASS 23 0.0212
84 IMPLANT SITE EROSION 6 0.0204
85 EXTRADURAL ABSCESS 16 0.0204
86 OPHTHALMOPLEGIA 32 0.0203
87 HYPERTENSIVE ENCEPHALOPATHY 12 0.0202
88 RADICULAR PAIN 7 0.0201
89 UREAPLASMA INFECTION 8 0.0196
90 IMPLANT SITE PAIN 87 0.0195
91 SPINAL EPIDURAL HAEMATOMA 11 0.0187
92 LOSS OF PROPRIOCEPTION 6 0.0186
93 HERPES SIMPLEX REACTIVATION 7 0.0184
94 SENSORIMOTOR DISORDER 9 0.0181
95 APGAR SCORE LOW 23 0.0178
96 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 6 0.0172
97 NERVE BLOCK 10 0.0171
98 PROCEDURAL HEADACHE 7 0.0171
99 CATHETER RELATED COMPLICATION 19 0.0169
100 CEREBROSPINAL FLUID LEAKAGE 31 0.0168
101 ECLAMPSIA 6 0.0163
102 CORNEAL REFLEX DECREASED 6 0.0160
103 PARAPLEGIA 46 0.0159
104 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 13 0.0158
105 ADMINISTRATION SITE SWELLING 5 0.0154
106 SEROMA 19 0.0149
107 SPINAL CORD INJURY 26 0.0149
108 SPHINCTER OF ODDI DYSFUNCTION 6 0.0146
109 MEDICAL DEVICE SITE INFECTION 9 0.0145
110 ANAL SPHINCTER ATONY 6 0.0140
111 IMPLANT SITE SWELLING 14 0.0137
112 DOSE CALCULATION ERROR 8 0.0137
113 BRAIN STEM SYNDROME 10 0.0133
114 SURGICAL PROCEDURE REPEATED 9 0.0131
115 IMPLANT SITE INFECTION 30 0.0129
116 AREFLEXIA 34 0.0127
117 DRUG EFFECT PROLONGED 7 0.0127
118 DEVICE ALARM ISSUE 23 0.0127
119 NORMAL NEWBORN 68 0.0125
120 IMPLANT SITE SCAR 9 0.0120
121 ENDOTRACHEAL INTUBATION COMPLICATION 7 0.0119
122 ANASTOMOTIC LEAK 8 0.0115
123 TRYPTASE INCREASED 8 0.0112
124 VASOPLEGIA SYNDROME 18 0.0110
125 INCISION SITE ERYTHEMA 5 0.0109
126 POSTPARTUM HAEMORRHAGE 14 0.0104
127 ALLODYNIA 12 0.0103
128 SINUS ARREST 16 0.0102
129 ELECTROMECHANICAL DISSOCIATION 8 0.0100
130 HYPERCAPNIA 30 0.0100
131 LOW BIRTH WEIGHT BABY 79 0.0099
132 RETINAL ARTERY OCCLUSION 25 0.0099
133 RESPIRATORY DEPRESSION 120 0.0098
134 CANCER PAIN 25 0.0098
135 EXOPHTHALMOS 21 0.0098
136 KOUNIS SYNDROME 22 0.0097
137 HYPERAESTHESIA 79 0.0096
138 ADRENAL SUPPRESSION 8 0.0095
139 INCISION SITE PAIN 11 0.0094
140 STAPHYLOCOCCAL ABSCESS 6 0.0093
141 INTRACRANIAL HYPOTENSION 6 0.0092
142 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 10 0.0091
143 MYELITIS 14 0.0090
144 MYOCLONUS 106 0.0089
145 MUSCLE NECROSIS 8 0.0088
146 SOFT TISSUE NECROSIS 6 0.0087
147 SPINAL CORD COMPRESSION 34 0.0087
148 MEDICAL DEVICE SITE DISCOMFORT 7 0.0087
149 FOETAL HEART RATE ABNORMAL 8 0.0086
150 DIPLEGIA 17 0.0086
151 AUTONOMIC NERVOUS SYSTEM IMBALANCE 25 0.0085
152 MYELITIS TRANSVERSE 12 0.0085
153 FANCONI SYNDROME 12 0.0085
154 SENSORY LOSS 68 0.0084
155 MEDICAL DEVICE DISCOMFORT 25 0.0082
156 PARESIS 18 0.0081
157 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 49 0.0080
158 FOETAL DISTRESS SYNDROME 17 0.0080
159 APNOEA 62 0.0080
160 IATROGENIC INJURY 10 0.0078
161 IMPLANT SITE ERYTHEMA 8 0.0077
162 NO THERAPEUTIC RESPONSE 91 0.0075
163 BRADYARRHYTHMIA 12 0.0073
164 PARAPARESIS 13 0.0073
165 LIVE BIRTH 60 0.0072
166 LUPUS VULGARIS 9 0.0071
167 SUBCUTANEOUS EMPHYSEMA 7 0.0071
168 WOUND DEHISCENCE 24 0.0071
169 POSTOPERATIVE WOUND COMPLICATION 9 0.0071
170 DEAFNESS BILATERAL 12 0.0071
171 PERONEAL NERVE PALSY 40 0.0070
172 GRANULOMA 24 0.0069
173 DEVICE KINK 25 0.0069
174 MYELOPATHY 13 0.0068
175 AXILLARY PAIN 10 0.0067
176 PREMATURE BABY 202 0.0067
177 SPINAL CORD DISORDER 11 0.0067
178 PREMATURE DELIVERY 106 0.0067
179 RESPIRATORY ACIDOSIS 26 0.0066
180 DEEP VEIN THROMBOSIS POSTOPERATIVE 13 0.0065
181 TACHYARRHYTHMIA 16 0.0064
182 WRONG PRODUCT ADMINISTERED 42 0.0062
183 PERFORMANCE STATUS DECREASED 29 0.0062
184 MUSCLE SPASTICITY 76 0.0062
185 CATHETER SITE PAIN 16 0.0062
186 ENDOTRACHEAL INTUBATION 17 0.0061
187 BREAKTHROUGH PAIN 14 0.0060
188 HYPOTHERMIA 61 0.0060
189 AMAUROSIS 5 0.0059
190 HYPOGONADISM 6 0.0059
191 DEVICE FAILURE 90 0.0059
192 BLOOD PRESSURE IMMEASURABLE 9 0.0059
193 POST PROCEDURAL COMPLICATION 108 0.0056
194 PARALYSIS 79 0.0055
195 ARRHYTHMIA SUPRAVENTRICULAR 6 0.0055
196 SEDATION COMPLICATION 14 0.0055
197 COMPLEX REGIONAL PAIN SYNDROME 8 0.0054
198 RESPIRATORY RATE DECREASED 17 0.0054
199 THERAPEUTIC PRODUCT EFFECT VARIABLE 21 0.0054
200 EXPOSURE DURING PREGNANCY 336 0.0054
201 SEDATION 141 0.0054
202 VITH NERVE PARALYSIS 6 0.0053
203 PULSELESS ELECTRICAL ACTIVITY 22 0.0053
204 HAEMODYNAMIC INSTABILITY 40 0.0052
205 INADEQUATE ANALGESIA 44 0.0052
206 DEAFNESS NEUROSENSORY 17 0.0052
207 HYPORESPONSIVE TO STIMULI 6 0.0051
208 PROCEDURAL COMPLICATION 39 0.0051
209 MONOPLEGIA 22 0.0051
210 POSTOPERATIVE WOUND INFECTION 34 0.0050
211 MONOPARESIS 9 0.0050
212 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
213 SACROILIITIS 9 0.0048
214 POST PROCEDURAL HAEMATOMA 8 0.0047
215 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
216 HYPOPNOEA 16 0.0046
217 HYPERAMMONAEMIC ENCEPHALOPATHY 8 0.0046
218 PREMATURE SEPARATION OF PLACENTA 7 0.0045
219 HYPERTROPHIC CARDIOMYOPATHY 7 0.0045
220 URINARY RETENTION 149 0.0045
221 STRIDOR 13 0.0044
222 PULSE ABSENT 21 0.0044
223 CAESAREAN SECTION 51 0.0044
224 UNRESPONSIVE TO STIMULI 113 0.0044
225 VENTRICULAR ARRHYTHMIA 16 0.0044
226 QUADRIPLEGIA 9 0.0044
227 CYSTITIS INTERSTITIAL 7 0.0043
228 GENERALISED TONIC-CLONIC SEIZURE 72 0.0043
229 FOETAL GROWTH RESTRICTION 26 0.0043
230 MATERNAL EXPOSURE DURING PREGNANCY 379 0.0042
231 HYPERTENSIVE EMERGENCY 5 0.0042
232 NEONATAL RESPIRATORY DISTRESS SYNDROME 15 0.0042
233 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
234 MENINGITIS BACTERIAL 6 0.0042
235 PREMATURE RUPTURE OF MEMBRANES 10 0.0041
236 CONVERSION DISORDER 8 0.0041
237 MOTOR DYSFUNCTION 42 0.0041
238 ANAL INCONTINENCE 37 0.0041
239 PERIPHERAL SENSORIMOTOR NEUROPATHY 5 0.0040
240 MYOCLONIC EPILEPSY 6 0.0040
241 BRADYCARDIA 209 0.0039
242 MENTAL STATUS CHANGES 109 0.0039
243 METHAEMOGLOBINAEMIA 9 0.0039
244 BUNDLE BRANCH BLOCK LEFT 16 0.0038
245 HYPOVOLAEMIA 22 0.0038
246 PROCEDURAL PAIN 104 0.0037
247 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
248 HYPOGLYCAEMIA NEONATAL 6 0.0037
249 PRODUCT PACKAGING CONFUSION 9 0.0037
250 NECROTISING FASCIITIS 13 0.0037
251 EMERGENCY CARE 11 0.0036
252 QUADRIPARESIS 6 0.0036
253 ILEUS PARALYTIC 16 0.0036
254 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 8 0.0036
255 RECTAL ABSCESS 6 0.0036
256 MEDICAL DEVICE COMPLICATION 26 0.0035
257 ARTERIOSPASM CORONARY 14 0.0035
258 RETINITIS 6 0.0035
259 VENTRICULAR HYPOKINESIA 11 0.0034
260 FACET JOINT SYNDROME 11 0.0034
261 HYPERTHERMIA MALIGNANT 5 0.0034
262 VOCAL CORD PARALYSIS 6 0.0033
263 BRADYPNOEA 9 0.0033
264 DYSAESTHESIA 10 0.0033
265 COMPLICATION ASSOCIATED WITH DEVICE 47 0.0032
266 HYPOTONIA 32 0.0032
267 DRUG WITHDRAWAL SYNDROME 281 0.0032
268 MATERNAL EXPOSURE TIMING UNSPECIFIED 12 0.0032
269 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 7 0.0032
270 DRUG TOLERANCE 16 0.0032
271 PRE-ECLAMPSIA 15 0.0032
272 VENTRICULAR FIBRILLATION 35 0.0031
273 DEVICE POWER SOURCE ISSUE 9 0.0031
274 DISLOCATION OF VERTEBRA 7 0.0031
275 COMPARTMENT SYNDROME 8 0.0031
276 NERVE INJURY 34 0.0031
277 CATATONIA 16 0.0030
278 INJECTION SITE ATROPHY 5 0.0030
279 PARADOXICAL DRUG REACTION 11 0.0030
280 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
281 CEREBELLAR INFARCTION 5 0.0030
282 ANAPHYLACTIC SHOCK 76 0.0029
283 CIRCULATORY COLLAPSE 50 0.0029
284 URINARY HESITATION 7 0.0029
285 BLOOD PH DECREASED 5 0.0029
286 HYPOXIA 103 0.0029
287 GRAND MAL CONVULSION 27 0.0029
288 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
289 MENINGITIS ASEPTIC 13 0.0029
290 BRAIN INJURY 29 0.0029
291 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
292 DEVICE CONNECTION ISSUE 6 0.0028
293 KYPHOSIS 5 0.0028
294 SWOLLEN JOINT COUNT INCREASED 9 0.0028
295 PRODUCT ADMINISTRATION ERROR 57 0.0028
296 FOETAL EXPOSURE DURING PREGNANCY 229 0.0028
297 HYPOTENSION 548 0.0027
298 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 9 0.0027
299 FAECAL INCONTINENCE 13 0.0027
300 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
301 CREPITATIONS 8 0.0027
302 VENTRICULAR TACHYCARDIA 44 0.0027
303 INTERVERTEBRAL DISCITIS 5 0.0026
304 MECHANICAL VENTILATION 5 0.0026
305 BRAIN DEATH 8 0.0026
306 ATROPHY 5 0.0026
307 HYPOAESTHESIA 381 0.0025
308 VITREOUS HAEMORRHAGE 7 0.0025
309 PRESCRIBED OVERDOSE 49 0.0025
310 EMPYEMA 5 0.0025
311 HEARING IMPAIRED 15 0.0025
312 ACUTE PULMONARY OEDEMA 14 0.0025
313 STUPOR 8 0.0025
314 NEURALGIA 60 0.0025
315 HYPOVENTILATION 8 0.0025
316 CARDIAC ARREST 200 0.0024
317 HYPERPARATHYROIDISM SECONDARY 6 0.0024
318 ISCHAEMIA 11 0.0024
319 POTENTIATING DRUG INTERACTION 8 0.0024
320 STRABISMUS 7 0.0024
321 ATELECTASIS 23 0.0024
322 ARTHRITIS INFECTIVE 11 0.0024
323 MEDICAL DEVICE PAIN 5 0.0023
324 SINUS TACHYCARDIA 33 0.0023
325 TRANSFUSION 24 0.0023
326 PRODUCT PREPARATION ISSUE 15 0.0023
327 NEUROTOXICITY 40 0.0023
328 RADICULOPATHY 6 0.0023
329 ENDOMETRIAL CANCER 5 0.0023
330 HYPERTONIA 13 0.0023
331 YAWNING 6 0.0022
332 RHEUMATIC FEVER 10 0.0022
333 SEROTONIN SYNDROME 43 0.0022
334 LARYNGOSPASM 6 0.0022
335 RESPIRATORY ARREST 61 0.0022
336 COMPUTERISED TOMOGRAM ABNORMAL 5 0.0022
337 DISTRIBUTIVE SHOCK 5 0.0022
338 PERIPHERAL ISCHAEMIA 9 0.0022
339 DEVICE OCCLUSION 31 0.0022
340 ARTHRITIS BACTERIAL 9 0.0022
341 HICCUPS 18 0.0022
342 CLONUS 6 0.0022
343 WOUND INFECTION 24 0.0022
344 MUSCLE RIGIDITY 26 0.0022
345 NEUROLOGICAL DECOMPENSATION 5 0.0022
346 STATUS EPILEPTICUS 24 0.0021
347 DEPRESSED LEVEL OF CONSCIOUSNESS 84 0.0021
348 PREMATURE LABOUR 12 0.0021
349 ANAPHYLACTIC REACTION 116 0.0021
350 NEUROLOGICAL SYMPTOM 12 0.0021
351 NYSTAGMUS 11 0.0021
352 DIPLOPIA 53 0.0020
353 JOINT RANGE OF MOTION DECREASED 27 0.0020
354 BRAIN HERNIATION 6 0.0020
355 METABOLIC ENCEPHALOPATHY 6 0.0020
356 MIOSIS 16 0.0020
357 TYPE I HYPERSENSITIVITY 7 0.0020
358 EMBOLISM VENOUS 6 0.0020
359 SINUS BRADYCARDIA 19 0.0020
360 NEPHROGENIC ANAEMIA 9 0.0019
361 SKIN NECROSIS 10 0.0019
362 URINARY INCONTINENCE 57 0.0019
363 DELIRIUM 65 0.0019
364 FORMICATION 13 0.0019
365 MUSCULAR WEAKNESS 212 0.0019
366 DRUG EXPOSURE DURING PREGNANCY 63 0.0019
367 RESPIRATORY DISTRESS 51 0.0018
368 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 12 0.0018
369 DECUBITUS ULCER 15 0.0018
370 MATERNAL DRUGS AFFECTING FOETUS 14 0.0018
371 SUBDURAL HAEMATOMA 26 0.0018
372 SENSORY DISTURBANCE 29 0.0018
373 HYPERAMMONAEMIA 9 0.0018
374 PROCEDURAL HAEMORRHAGE 7 0.0018
375 ELECTRIC SHOCK SENSATION 5 0.0018
376 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
377 WOUND COMPLICATION 6 0.0017
378 VENTRICULAR EXTRASYSTOLES 18 0.0017
379 HYPERTONIC BLADDER 5 0.0017
380 HYPERREFLEXIA 6 0.0017
381 EXTRA DOSE ADMINISTERED 69 0.0017
382 PULMONARY TOXICITY 12 0.0017
383 ILEUS 21 0.0017
384 BRONCHOSPASM 24 0.0017
385 WITHDRAWAL SYNDROME 70 0.0017
386 CYANOSIS 26 0.0017
387 BLOOD DISORDER 13 0.0016
388 DRUG TOXICITY 22 0.0016
389 ACUTE RESPIRATORY FAILURE 31 0.0016
390 HYPOAESTHESIA ORAL 24 0.0016
391 THERAPY NON-RESPONDER 71 0.0016
392 HYPERTHERMIA 12 0.0016
393 CARDIOTOXICITY 14 0.0016
394 MYOSITIS 14 0.0016
395 RHEUMATOID FACTOR POSITIVE 9 0.0016
396 STRESS CARDIOMYOPATHY 9 0.0015
397 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 12 0.0015
398 WOUND SECRETION 6 0.0015
399 ACCIDENTAL OVERDOSE 55 0.0015
400 METASTASES TO SPINE 5 0.0015
401 SPINAL COLUMN STENOSIS 7 0.0015
402 DUODENAL ULCER PERFORATION 11 0.0015
403 POST PROCEDURAL HAEMORRHAGE 17 0.0015
404 EXTRAVASATION 6 0.0015
405 WRONG DRUG ADMINISTERED 13 0.0015
406 OLIGURIA 9 0.0014
407 DEVICE DISLOCATION 63 0.0014
408 MUSCLE INJURY 12 0.0014
409 HEART RATE ABNORMAL 8 0.0014
410 BLEPHAROSPASM 9 0.0014
411 RESPIRATORY FAILURE 104 0.0014
412 BONE EROSION 5 0.0014
413 FACIAL PARESIS 5 0.0014
414 ABSCESS LIMB 6 0.0014
415 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
416 PNEUMOTHORAX 22 0.0014
417 TACHYCARDIA 123 0.0014
418 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
419 SCIATICA 22 0.0014
420 LOSS OF CONSCIOUSNESS 173 0.0013
421 WHEELCHAIR USER 6 0.0013
422 BRAIN OEDEMA 17 0.0013
423 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
424 BLOOD PRESSURE DECREASED 89 0.0013
425 SUSPECTED OFF LABEL USE 6 0.0013
426 HEPATIC NECROSIS 5 0.0013
427 PAROSMIA 10 0.0013
428 BODY TEMPERATURE DECREASED 13 0.0013
429 EYE MOVEMENT DISORDER 9 0.0013
430 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
431 THERAPEUTIC RESPONSE SHORTENED 43 0.0013
432 MUSCLE TIGHTNESS 21 0.0013
433 AGITATION 95 0.0013
434 CARDIO-RESPIRATORY ARREST 54 0.0013
435 PULMONARY CONGESTION 17 0.0013
436 DYSTONIA 25 0.0013
437 UMBILICAL HERNIA 6 0.0013
438 FAECALOMA 7 0.0013
439 ENCEPHALOPATHY 31 0.0013
440 NECROSIS 7 0.0013
441 PAIN 772 0.0013
442 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 9 0.0013
443 EXPOSURE VIA BREAST MILK 5 0.0013
444 SPINAL OSTEOARTHRITIS 11 0.0013
445 INTRAOCULAR PRESSURE INCREASED 16 0.0013
446 GRIP STRENGTH DECREASED 11 0.0012
447 MYDRIASIS 16 0.0012
448 HEART RATE DECREASED 43 0.0012
449 PERIPHERAL VENOUS DISEASE 5 0.0012
450 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
451 ANAPHYLACTOID REACTION 5 0.0012
452 HYPERHIDROSIS 156 0.0012
453 PRODUCT LABEL CONFUSION 7 0.0012
454 MENINGITIS 8 0.0012
455 NO ADVERSE EVENT 217 0.0012
456 OXYGEN SATURATION DECREASED 67 0.0012
457 TACHYPNOEA 16 0.0012
458 THERAPEUTIC RESPONSE DECREASED 71 0.0012
459 ATRIOVENTRICULAR BLOCK 9 0.0012
460 DISORIENTATION 46 0.0012
461 APLASTIC ANAEMIA 6 0.0011
462 HYPERCHOLESTEROLAEMIA 11 0.0011
463 JOINT DISLOCATION 12 0.0011
464 AUTOIMMUNE DISORDER 11 0.0011
465 IMPAIRED HEALING 37 0.0011
466 APHASIA 34 0.0011
467 METABOLIC ACIDOSIS 36 0.0011
468 INCORRECT ROUTE OF DRUG ADMINISTRATION 40 0.0011
469 MEDICATION ERROR 62 0.0011
470 IMPAIRED GASTRIC EMPTYING 15 0.0011
471 OVERDOSE 235 0.0011
472 SPINAL COMPRESSION FRACTURE 9 0.0011
473 BREAST CANCER STAGE III 7 0.0011
474 PARAESTHESIA 170 0.0011
475 SUBARACHNOID HAEMORRHAGE 11 0.0011
476 SEIZURE 124 0.0011
477 BURSITIS 13 0.0011
478 ADRENAL INSUFFICIENCY 13 0.0011
479 HELICOBACTER INFECTION 11 0.0011
480 SOMNOLENCE 214 0.0011
481 SMALL INTESTINAL OBSTRUCTION 13 0.0011
482 FACIAL PARALYSIS 9 0.0011
483 MYOCARDIAL ISCHAEMIA 12 0.0011
484 DEVICE MALFUNCTION 74 0.0011
485 COMA 50 0.0010
486 PULMONARY OEDEMA 47 0.0010
487 HAEMATOMA 27 0.0010
488 OFF LABEL USE 905 0.0010
489 RALES 6 0.0010
490 NERVOUS SYSTEM DISORDER 32 0.0010
491 GROIN PAIN 9 0.0010
492 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
493 ASPIRATION 11 0.0010
494 APHONIA 14 0.0010
495 EXTRASYSTOLES 7 0.0010
496 LETHARGY 57 0.0010
497 EYELID PTOSIS 10 0.0010
498 RETINAL HAEMORRHAGE 7 0.0010
499 DRUG INTERACTION 155 0.0010
500 PANIC REACTION 7 0.0010
501 PERSONALITY CHANGE 9 0.0010
502 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
503 FOETAL DEATH 5 0.0010
504 PERIORBITAL OEDEMA 5 0.0010
505 PARTIAL SEIZURES 5 0.0010
506 MUSCLE TWITCHING 22 0.0010
507 MUSCULOSKELETAL PAIN 50 0.0010
508 INCONTINENCE 10 0.0009
509 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
510 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
511 STAPHYLOCOCCAL INFECTION 31 0.0009
512 MASS 13 0.0009
513 ATAXIA 11 0.0009
514 HOSPITALISATION 142 0.0009
515 ADVERSE DRUG REACTION 83 0.0009
516 HYDROCEPHALUS 5 0.0009
517 ACIDOSIS 7 0.0009
518 TINNITUS 42 0.0009
519 BLADDER DISORDER 9 0.0009
520 MOVEMENT DISORDER 29 0.0009
521 TOXICITY TO VARIOUS AGENTS 149 0.0009
522 LIP DRY 8 0.0009
523 SCAR 15 0.0009
524 OSTEOARTHRITIS 37 0.0009
525 THERAPEUTIC PRODUCT EFFECT DECREASED 39 0.0009
526 JOINT EFFUSION 6 0.0009
527 OEDEMA 47 0.0009
528 HYPERVENTILATION 5 0.0009
529 EYELID OEDEMA 10 0.0009
530 SHOCK HAEMORRHAGIC 7 0.0009
531 FOLLICULITIS 9 0.0009
532 ERYTHEMA MULTIFORME 8 0.0009
533 HALLUCINATION, VISUAL 18 0.0009
534 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
535 DISCOMFORT 52 0.0009
536 RESTLESSNESS 31 0.0008
537 THERMAL BURN 6 0.0008
538 SPINAL DISORDER 8 0.0008
539 HAND DEFORMITY 11 0.0008
540 CARDIOGENIC SHOCK 12 0.0008
541 ACCIDENTAL UNDERDOSE 12 0.0008
542 HEPATITIS CHOLESTATIC 5 0.0008
543 BURNING SENSATION 58 0.0008
544 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
545 LARYNGEAL OEDEMA 5 0.0008
546 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
547 ROAD TRAFFIC ACCIDENT 33 0.0008
548 TROPONIN INCREASED 6 0.0008
549 COORDINATION ABNORMAL 11 0.0008
550 RESPIRATORY RATE INCREASED 7 0.0008
551 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
552 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
553 CONFUSIONAL STATE 125 0.0008
554 ABASIA 19 0.0008
555 EXOSTOSIS 7 0.0008
556 BRADYPHRENIA 5 0.0008
557 TORSADE DE POINTES 6 0.0008
558 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
559 DYSKINESIA 31 0.0008
560 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
561 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
562 OBESITY 12 0.0008
563 ACUTE MYOCARDIAL INFARCTION 22 0.0007
564 DRUG EFFECT DECREASED 40 0.0007
565 BACK PAIN 172 0.0007
566 DEVICE LEAKAGE 32 0.0007
567 MUSCLE SPASMS 135 0.0007
568 PEMPHIGUS 9 0.0007
569 LEUKOCYTOSIS 13 0.0007
570 HIP ARTHROPLASTY 11 0.0007
571 DYSARTHRIA 27 0.0007
572 PERICARDITIS 12 0.0007
573 END STAGE RENAL DISEASE 13 0.0007
574 DYSURIA 26 0.0007
575 BRAIN FOG 11 0.0007
576 DRUG-INDUCED LIVER INJURY 22 0.0007
577 PARAESTHESIA ORAL 10 0.0007
578 HYPOKINESIA 10 0.0007
579 HEART RATE INCREASED 68 0.0007
580 EUPHORIC MOOD 7 0.0007
581 CONVULSION 39 0.0007
582 LOWER LIMB FRACTURE 13 0.0007
583 HYPOPHOSPHATAEMIA 5 0.0007
584 TENDERNESS 7 0.0007
585 HYPERTENSION 142 0.0007
586 DEVICE ISSUE 59 0.0007
587 IRRITABLE BOWEL SYNDROME 14 0.0007
588 SHOCK 15 0.0007
589 DRUG ADMINISTRATION ERROR 20 0.0007
590 UROSEPSIS 6 0.0006
591 NERVE COMPRESSION 6 0.0006
592 DEVICE RELATED INFECTION 10 0.0006
593 SPINAL OPERATION 8 0.0006
594 HEMIPARESIS 11 0.0006
595 UNEVALUABLE EVENT 49 0.0006
596 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
597 WOUND 18 0.0006
598 COGNITIVE DISORDER 30 0.0006
599 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
600 FLANK PAIN 6 0.0006
601 RESPIRATORY DISORDER 19 0.0006
602 VISUAL ACUITY REDUCED 21 0.0006
603 HALLUCINATION, AUDITORY 10 0.0006
604 SLEEP APNOEA SYNDROME 12 0.0006
605 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
606 MALNUTRITION 7 0.0006
607 BLOOD PRESSURE FLUCTUATION 15 0.0006
608 PALLOR 17 0.0006
609 BLOOD PRESSURE INCREASED 94 0.0006
610 HAEMORRHAGE 64 0.0006
611 DYSGEUSIA 45 0.0006
612 ACUTE CORONARY SYNDROME 5 0.0006
613 FEELING HOT 37 0.0006
614 UNDERDOSE 44 0.0006
615 ELECTROLYTE IMBALANCE 7 0.0006
616 PNEUMONIA ASPIRATION 15 0.0006
617 SPINAL PAIN 7 0.0006
618 MUSCULOSKELETAL STIFFNESS 52 0.0006
619 PLEURAL EFFUSION 36 0.0006
620 NECK PAIN 33 0.0006
621 CHILLS 69 0.0006
622 NEUTROPHIL COUNT INCREASED 6 0.0006
623 VOMITING 275 0.0006
624 MOBILITY DECREASED 42 0.0006
625 ANURIA 5 0.0006
626 DELUSION 9 0.0006
627 CARDIAC MURMUR 5 0.0006
628 MENTAL IMPAIRMENT 14 0.0006
629 HYSTERECTOMY 5 0.0006
630 ARRHYTHMIA 27 0.0006
631 CARDIOMEGALY 7 0.0006
632 GAIT INABILITY 19 0.0006
633 COLD SWEAT 10 0.0006
634 LUNG INFILTRATION 5 0.0006
635 HYPOKALAEMIA 26 0.0006
636 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
637 DRUG INEFFECTIVE 736 0.0006
638 HAEMOLYTIC ANAEMIA 5 0.0006
639 HALLUCINATION 42 0.0006
640 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
641 ABNORMAL BEHAVIOUR 22 0.0006
642 SYNOVITIS 10 0.0006
643 SPEECH DISORDER 29 0.0006
644 MUSCLE ATROPHY 7 0.0006
645 OSTEOMYELITIS 10 0.0006
646 LUPUS-LIKE SYNDROME 5 0.0006
647 INFUSION SITE PAIN 7 0.0005
648 TREMOR 90 0.0005
649 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
650 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
651 RESPIRATORY TRACT INFECTION 14 0.0005
652 GLOSSODYNIA 12 0.0005
653 SWELLING 50 0.0005
654 JOINT STIFFNESS 14 0.0005
655 BEDRIDDEN 7 0.0005
656 CONDITION AGGRAVATED 161 0.0005
657 MUSCULOSKELETAL DISORDER 10 0.0005
658 ANXIETY 149 0.0005
659 NAUSEA 414 0.0005
660 PRODUCT USE ISSUE 97 0.0005
661 ATRIAL FIBRILLATION 50 0.0005
662 SWOLLEN TONGUE 16 0.0005
663 SURGERY 30 0.0005
664 PERIPHERAL COLDNESS 7 0.0005
665 HEPATITIS 13 0.0005
666 BACTERAEMIA 6 0.0005
667 ASTHENIA 189 0.0005
668 OEDEMA PERIPHERAL 61 0.0005
669 PREGNANCY 10 0.0005
670 CELLULITIS 25 0.0005
671 TREATMENT FAILURE 41 0.0005
672 FIBROMYALGIA 12 0.0005
673 AMNESIA 32 0.0005
674 INFECTION 71 0.0005
675 BODY TEMPERATURE INCREASED 10 0.0005
676 BALANCE DISORDER 42 0.0005
677 LIMB DISCOMFORT 15 0.0005
678 CONSTIPATION 105 0.0005
679 BLISTER 27 0.0005
680 DYSSTASIA 14 0.0005
681 PHOTOPHOBIA 9 0.0005
682 DEEP VEIN THROMBOSIS 31 0.0005
683 WHEEZING 28 0.0005
684 SYNCOPE 47 0.0005
685 INJURY 33 0.0005
686 ROTATOR CUFF SYNDROME 6 0.0005
687 PARANOIA 8 0.0005
688 ECONOMIC PROBLEM 7 0.0005
689 DYSPHONIA 27 0.0005
690 BACK INJURY 5 0.0005
691 LOCAL SWELLING 8 0.0005
692 DRUG DISPENSING ERROR 7 0.0005
693 FOOT DEFORMITY 5 0.0005
694 INTESTINAL OBSTRUCTION 17 0.0005
695 FALL 150 0.0005
696 EJECTION FRACTION DECREASED 7 0.0004
697 CHRONIC KIDNEY DISEASE 34 0.0004
698 QUALITY OF LIFE DECREASED 6 0.0004
699 TYPE 2 DIABETES MELLITUS 15 0.0004
700 SWELLING FACE 29 0.0004
701 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
702 EXTRAPYRAMIDAL DISORDER 11 0.0004
703 IMPAIRED DRIVING ABILITY 5 0.0004
704 C-REACTIVE PROTEIN INCREASED 16 0.0004
705 AKATHISIA 6 0.0004
706 PANIC ATTACK 16 0.0004
707 ABDOMINAL PAIN 102 0.0004
708 PULMONARY HYPERTENSION 9 0.0004
709 PULMONARY EMBOLISM 41 0.0004
710 CARPAL TUNNEL SYNDROME 6 0.0004
711 HEPATIC CIRRHOSIS 8 0.0004
712 SKIN ULCER 11 0.0004
713 EPILEPSY 13 0.0004
714 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
715 DIZZINESS 211 0.0004
716 DRUG LEVEL INCREASED 7 0.0004
717 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
718 HYPERSENSITIVITY 78 0.0004
719 PAIN IN EXTREMITY 123 0.0004
720 PULMONARY FIBROSIS 8 0.0004
721 SEPTIC SHOCK 18 0.0004
722 RHABDOMYOLYSIS 17 0.0004
723 POLLAKIURIA 17 0.0004
724 GAIT DISTURBANCE 78 0.0004
725 LIVER INJURY 10 0.0004
726 MUSCULOSKELETAL DISCOMFORT 7 0.0004
727 DISABILITY 8 0.0004
728 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
729 SEPSIS 45 0.0004
730 HAEMATOCRIT DECREASED 8 0.0004
731 PRESCRIBED UNDERDOSE 8 0.0004
732 SKIN LESION 11 0.0004
733 ACUTE KIDNEY INJURY 61 0.0004
734 SLEEP DISORDER 28 0.0004
735 LYMPHOCYTE COUNT DECREASED 7 0.0004
736 HAEMOGLOBIN DECREASED 40 0.0004
737 DISTURBANCE IN ATTENTION 21 0.0004
738 OSTEOPOROSIS 16 0.0004
739 URTICARIA 65 0.0004
740 ANKLE FRACTURE 6 0.0004
741 DYSPNOEA 217 0.0004
742 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
743 PRURITUS 146 0.0004
744 IMMUNE SYSTEM DISORDER 5 0.0004
745 CHEST PAIN 70 0.0004
746 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
747 CARDIAC DISORDER 35 0.0004
748 NIGHT SWEATS 12 0.0004
749 FEAR 10 0.0004
750 PRESYNCOPE 9 0.0004
751 INFLAMMATION 19 0.0004
752 NEUROPATHY PERIPHERAL 35 0.0004
753 VISION BLURRED 50 0.0004
754 COAGULOPATHY 6 0.0004
755 FEELING COLD 10 0.0004
756 HYPOMAGNESAEMIA 5 0.0004
757 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
758 INSOMNIA 95 0.0004
759 BLINDNESS UNILATERAL 5 0.0004
760 HEPATOCELLULAR INJURY 5 0.0004
761 CHEST DISCOMFORT 36 0.0004
762 MEMORY IMPAIRMENT 48 0.0003
763 SPINAL FRACTURE 7 0.0003
764 ANGINA PECTORIS 10 0.0003
765 HYPOACUSIS 15 0.0003
766 IMPAIRED QUALITY OF LIFE 5 0.0003
767 LUNG DISORDER 17 0.0003
768 HYPERTHYROIDISM 5 0.0003
769 DEVICE BREAKAGE 14 0.0003
770 DEAFNESS 9 0.0003
771 APATHY 5 0.0003
772 CONTUSION 33 0.0003
773 PRODUCT PREPARATION ERROR 7 0.0003
774 RIB FRACTURE 7 0.0003
775 ANGIOEDEMA 15 0.0003
776 PSYCHOTIC DISORDER 10 0.0003
777 CARDIOMYOPATHY 5 0.0003
778 HEPATIC ENZYME INCREASED 23 0.0003
779 INCORRECT DOSE ADMINISTERED 77 0.0003
780 ERYTHEMA 69 0.0003
781 THROAT TIGHTNESS 9 0.0003
782 KNEE ARTHROPLASTY 7 0.0003
783 CRYING 12 0.0003
784 HYPOGLYCAEMIA 16 0.0003
785 RETCHING 7 0.0003
786 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
787 PRODUCT USE IN UNAPPROVED INDICATION 81 0.0003
788 HEPATIC STEATOSIS 6 0.0003
789 THINKING ABNORMAL 6 0.0003
790 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 58 0.0003
791 BACTERIAL INFECTION 6 0.0003
792 DRY MOUTH 26 0.0003
793 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
794 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
795 NIGHTMARE 11 0.0003
796 RENAL FAILURE 42 0.0003
797 DYSPHAGIA 30 0.0003
798 IRRITABILITY 19 0.0003
799 FEELING JITTERY 6 0.0003
800 HYPOPHAGIA 8 0.0003
801 ORAL PAIN 7 0.0003
802 DRUG RESISTANCE 8 0.0003
803 DEPRESSION 70 0.0003
804 CHOKING 6 0.0003
805 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
806 FLUSHING 31 0.0003
807 URINARY TRACT INFECTION 52 0.0003
808 SKIN DISCOLOURATION 14 0.0003
809 ANHEDONIA 8 0.0003
810 COMPLICATION OF DEVICE INSERTION 6 0.0003
811 ACCIDENTAL EXPOSURE TO PRODUCT 31 0.0003
812 MENTAL DISORDER 13 0.0003
813 MALAISE 130 0.0003
814 PYREXIA 102 0.0003
815 HEADACHE 184 0.0003
816 RASH ERYTHEMATOUS 14 0.0003
817 FEELING ABNORMAL 70 0.0003
818 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
819 TOOTH LOSS 6 0.0003
820 PRODUCT QUALITY ISSUE 39 0.0003
821 DRUG INTOLERANCE 27 0.0003
822 LIVER FUNCTION TEST INCREASED 6 0.0003
823 INFLUENZA LIKE ILLNESS 23 0.0003
824 HYPERSOMNIA 8 0.0003
825 BLOOD CHOLESTEROL INCREASED 13 0.0003
826 POOR QUALITY SLEEP 6 0.0003
827 PRURITUS GENERALISED 6 0.0003
828 GASTROENTERITIS VIRAL 5 0.0003
829 CARDIOVASCULAR DISORDER 7 0.0003
830 BONE DISORDER 5 0.0003
831 JOINT SWELLING 33 0.0003
832 INFUSION RELATED REACTION 18 0.0003
833 ADVERSE EVENT 25 0.0003
834 STEVENS-JOHNSON SYNDROME 6 0.0003
835 GASTROINTESTINAL DISORDER 24 0.0003
836 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
837 BLOOD SODIUM DECREASED 5 0.0003
838 PALPITATIONS 31 0.0003
839 DYSPEPSIA 26 0.0003
840 FRACTURE 5 0.0003
841 ILL-DEFINED DISORDER 16 0.0003
842 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
843 PNEUMONIA 85 0.0003
844 SUICIDAL IDEATION 24 0.0003
845 WEIGHT DECREASED 73 0.0003
846 VISUAL IMPAIRMENT 32 0.0003
847 LIMB INJURY 7 0.0003
848 ORAL HERPES 5 0.0003
849 MOOD SWINGS 8 0.0003
850 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
851 NERVOUSNESS 13 0.0002
852 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
853 LIVER DISORDER 11 0.0002
854 DEHYDRATION 33 0.0002
855 PSORIATIC ARTHROPATHY 10 0.0002
856 CEREBRAL INFARCTION 6 0.0002
857 RED BLOOD CELL COUNT DECREASED 7 0.0002
858 CHOLELITHIASIS 8 0.0002
859 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
860 LIVER FUNCTION TEST ABNORMAL 7 0.0002
861 DERMATITIS 5 0.0002
862 RENAL INJURY 7 0.0002
863 JOINT INJURY 5 0.0002
864 ARTHROPATHY 13 0.0002
865 ARTHRALGIA 97 0.0002
866 HYPONATRAEMIA 13 0.0002
867 ABDOMINAL DISTENSION 24 0.0002
868 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
869 GASTRITIS 6 0.0002
870 EAR INFECTION 6 0.0002
871 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
872 PLATELET COUNT DECREASED 24 0.0002
873 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
874 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
875 HEPATOTOXICITY 5 0.0002
876 DECREASED APPETITE 52 0.0002
877 JAUNDICE 6 0.0002
878 FREQUENT BOWEL MOVEMENTS 6 0.0002
879 BLINDNESS 9 0.0002
880 HYPERGLYCAEMIA 8 0.0002
881 TREATMENT NONCOMPLIANCE 12 0.0002
882 INTENTIONAL OVERDOSE 14 0.0002
883 FLUID RETENTION 11 0.0002
884 RENAL DISORDER 10 0.0002
885 PERIPHERAL SWELLING 33 0.0002
886 EYE PAIN 12 0.0002
887 RENAL FAILURE ACUTE 9 0.0002
888 LIP SWELLING 7 0.0002
889 DIABETIC KETOACIDOSIS 5 0.0002
890 PANCREATIC CARCINOMA 6 0.0002
891 MYALGIA 35 0.0002
892 INTENTIONAL PRODUCT MISUSE 18 0.0002
893 INJECTION SITE URTICARIA 5 0.0002
894 OSTEONECROSIS OF JAW 5 0.0002
895 HYPERKALAEMIA 7 0.0002
896 STOMATITIS 12 0.0002
897 VERTIGO 12 0.0002
898 SINUSITIS 20 0.0002
899 MYOCARDIAL INFARCTION 34 0.0002
900 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
901 ERECTILE DYSFUNCTION 5 0.0002
902 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
903 MUCOSAL INFLAMMATION 5 0.0002
904 INJECTION SITE MASS 7 0.0002
905 BLOOD GLUCOSE DECREASED 9 0.0002
906 DISEASE PROGRESSION 22 0.0002
907 DYSPNOEA EXERTIONAL 7 0.0002
908 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
909 MOOD ALTERED 5 0.0002
910 OSTEONECROSIS 6 0.0002
911 DIVERTICULITIS 5 0.0002
912 MIGRAINE 17 0.0002
913 ARTHRITIS 14 0.0002
914 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
915 FATIGUE 138 0.0002
916 FLATULENCE 10 0.0002
917 CARDIAC FAILURE 14 0.0002
918 EMOTIONAL DISTRESS 21 0.0002
919 ABDOMINAL DISCOMFORT 29 0.0002
920 WEIGHT INCREASED 38 0.0002
921 DRUG ABUSE 14 0.0002
922 ASTHMA 19 0.0002
923 DRUG DEPENDENCE 27 0.0002
924 HEPATIC FAILURE 5 0.0002
925 LACRIMATION INCREASED 5 0.0002
926 CEREBROVASCULAR ACCIDENT 28 0.0002
927 DRUG EFFECT INCOMPLETE 6 0.0002
928 EMOTIONAL DISORDER 5 0.0002
929 FEMUR FRACTURE 5 0.0002
930 EYE SWELLING 6 0.0002
931 VAGINAL HAEMORRHAGE 7 0.0002
932 RASH 67 0.0002
933 PANCREATITIS 8 0.0002
934 CATARACT 9 0.0002
935 ABDOMINAL PAIN UPPER 31 0.0002
936 ANAEMIA 28 0.0001
937 HAEMATURIA 5 0.0001
938 HOT FLUSH 11 0.0001
939 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
940 INJECTION SITE REACTION 10 0.0001
941 DIARRHOEA 93 0.0001
942 AGGRESSION 7 0.0001
943 ALOPECIA 26 0.0001
944 COMPLETED SUICIDE 11 0.0001
945 NEPHROLITHIASIS 6 0.0001
946 NASOPHARYNGITIS 24 0.0001
947 RASH PRURITIC 7 0.0001
948 DRUG DOSE OMISSION 21 0.0001
949 DEATH 109 0.0001
950 MULTIPLE SCLEROSIS 6 0.0001
951 THROMBOCYTOPENIA 14 0.0001
952 CARDIAC FAILURE CONGESTIVE 10 0.0001
953 THROMBOSIS 10 0.0001
954 NEUTROPHIL COUNT DECREASED 5 0.0001
955 HERPES ZOSTER 7 0.0001
956 LUNG NEOPLASM MALIGNANT 5 0.0001
957 DIABETES MELLITUS 9 0.0001
958 DEPRESSED MOOD 6 0.0001
959 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
960 BLOOD CREATININE INCREASED 7 0.0001
961 RHEUMATOID ARTHRITIS 12 0.0001
962 OCULAR HYPERAEMIA 5 0.0001
963 NEOPLASM MALIGNANT 7 0.0001
964 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
965 COUGH 29 0.0001
966 BONE PAIN 6 0.0001
967 NASAL CONGESTION 6 0.0001
968 INJECTION SITE BRUISING 8 0.0001
969 DRY EYE 5 0.0001
970 LEUKOPENIA 5 0.0001
971 SUICIDE ATTEMPT 6 0.0001
972 INFLUENZA 11 0.0001
973 BRONCHITIS 7 0.0001
974 HAEMATOCHEZIA 5 0.0001
975 EYE IRRITATION 5 0.0001
976 OROPHARYNGEAL PAIN 8 0.0001
977 BLOOD GLUCOSE INCREASED 16 0.0001
978 RENAL IMPAIRMENT 7 0.0001
979 PRODUCT STORAGE ERROR 7 0.0001
980 ILLNESS 8 0.0001
981 FEBRILE NEUTROPENIA 5 0.0001
982 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
983 INJECTION SITE ERYTHEMA 8 0.0001
984 BREAST CANCER 6 0.0001
985 PSORIASIS 8 0.0001
986 PRODUCT DOSE OMISSION ISSUE 16 0.0001
987 DRY SKIN 7 0.0001
988 INJECTION SITE PAIN 16 0.0001
989 COVID-19 5 0.0000